Eaton Vance Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Eaton Vance Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15,471	Closed	-$1.44M	–	2893
2021 Q4	$1.44M	Hold	15,471	–	–	﹤0.01%	1106
2021 Q3	$921K	Hold	15,471	–	–	﹤0.01%	1110
2021 Q2	$1.05M	Buy	+15,471	New	+$1.01M	﹤0.01%	1159

Eaton Vance Management's ARNA Position: Q1 2022 in Review

Eaton Vance Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 15,471 shares — an estimated $1.44M sold.

Eaton Vance Management first reported a position in ARNA in Q2 2021 and held it in 3 quarters. The position peaked at $1.44M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Eaton Vance Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Eaton Vance Management sold 15,471 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.44M.
Eaton Vance Management first reported a position in Arena Pharmaceuticals Inc in Q2 2021 and held it in 3 quarters.
Eaton Vance Management's Arena Pharmaceuticals Inc position peaked at $1.44M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Eaton Vance Management's 13F filing for Q1 2022, filed 16 May 2022.